203 related articles for article (PubMed ID: 24463190)
1. Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
Wiezel D; Assadi MH; Landau D; Troib A; Kachko L; Rabkin R; Segev Y
Nephrol Dial Transplant; 2014 Apr; 29(4):791-9. PubMed ID: 24463190
[TBL] [Abstract][Full Text] [Related]
2. Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation.
Troib A; Landau D; Kachko L; Rabkin R; Segev Y
Kidney Int; 2013 Nov; 84(5):940-9. PubMed ID: 23715123
[TBL] [Abstract][Full Text] [Related]
3. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
[TBL] [Abstract][Full Text] [Related]
4. Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
Ugarte F; Irarrazabal C; Oh J; Dettmar A; Ceballos ML; Rojo A; Ibacache MJ; Suazo C; Lozano M; Delgado I; Cavada G; Azocar M; Delucchi A; Cano F
Pediatr Nephrol; 2016 Jun; 31(6):965-74. PubMed ID: 26747624
[TBL] [Abstract][Full Text] [Related]
5. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
6. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
[TBL] [Abstract][Full Text] [Related]
7. SOCS2 Silencing Improves Somatic Growth without Worsening Kidney Function in CKD.
Landau D; Assadi MH; Abu Hilal R; Chen Y; Rabkin R; Segev Y
Am J Nephrol; 2020; 51(7):520-526. PubMed ID: 32541140
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys.
Ocaranza P; Morales F; Matamala Á; Gaete X; Román R; Lammoglia JJ; Cassorla F
Growth Horm IGF Res; 2016 Apr; 27():18-27. PubMed ID: 26843474
[TBL] [Abstract][Full Text] [Related]
10. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age.
Huang Y; Du M; Zhuang S; Shen Z; Li Y
Horm Res Paediatr; 2010; 74(2):106-13. PubMed ID: 20395663
[TBL] [Abstract][Full Text] [Related]
11. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
16. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
Jørgensen JO; Jessen N; Pedersen SB; Vestergaard E; Gormsen L; Lund SA; Billestrup N
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E899-905. PubMed ID: 16757551
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes.
Ahmed TA; Buzzelli MD; Lang CH; Capen JB; Shumate ML; Navaratnarajah M; Nagarajan M; Cooney RN
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1793-803. PubMed ID: 17395896
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
20. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
